Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; Bristol-Myers Squibb Holdings Pharma, Ltd.; (Pharmaceuticals); Manati, Puerto Rico

 
CONTENT
Federal Register, Volume 84 Issue 185 (Tuesday, September 24, 2019)
[Federal Register Volume 84, Number 185 (Tuesday, September 24, 2019)]
[Notices]
[Page 49984]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20638]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-36-2019]
Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Authorization
of Production Activity; Bristol-Myers Squibb Holdings Pharma, Ltd.;
(Pharmaceuticals); Manati, Puerto Rico
    On May 13, 2019, Bristol-Myers Squibb Holdings Pharma, Ltd.
submitted a notification of proposed production activity to the FTZ
Board for its facility within FTZ 7, in Manati, Puerto Rico.
    The notification was processed in accordance with the regulations
of the FTZ Board (15 CFR part 400), including notice in the Federal
Register inviting public comment (84 FR 23759--23760, May 23, 2019). On
September 10, 2019, the applicant was notified of the FTZ Board's
decision that no further review of the activity is warranted at this
time. The production activity described in the notification was
authorized, subject to the FTZ Act and the FTZ Board's regulations,
including Section 400.14.
    Dated: September 16, 2019.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2019-20638 Filed 9-23-19; 8:45 am]
BILLING CODE 3510-DS-P